Search research articles
Contact Us
Filters
Showing results (71-80 of 238) with videos related to
Page
of 24
Sort By:
The Journal of Biological Chemistry
|
June 27, 1997
Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth
J A Engelman, C C Wykoff, S Yasuhara, et al.
Science Signaling
|
November 25, 2010
BRAF gene amplification can promote acquired resistance to MEK inhibitors in cancer cells harboring the BRAF V600E mutation
Ryan B Corcoran, Dora Dias-Santagata, Kristin Bergethon, et al.
Oncogene
|
June 29, 2010
H1047R phosphatidylinositol 3-kinase mutant enhances HER2-mediated transformation by heregulin production and activation of HER3
A Chakrabarty, B N Rexer, S E Wang, et al.
The Journal of Biological Chemistry
|
December 10, 1999
Constitutively active mitogen-activated protein kinase kinase 6 (MKK6) or salicylate induces spontaneous 3T3-L1 adipogenesis
J A Engelman, A H Berg, R Y Lewis, et al.
The EMBO Journal
|
November 21, 1998
Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade
F Galbiati, D Volonte, J A Engelman, et al.
Cancer Research
|
May 4, 2012
MEK inhibition leads to PI3K/AKT activation by relieving a negative feedback on ERBB receptors
Alexa B Turke, Youngchul Song, Carlotta Costa, et al.
Cancer Research
|
January 27, 2011
Multiple mutations and bypass mechanisms can contribute to development of acquired resistance to MET inhibitors
Jie Qi, Michele A McTigue, Andrew Rogers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 19, 2007
Human breast cancer cells selected for resistance to trastuzumab in vivo overexpress epidermal growth factor receptor and ErbB ligands and remain dependent on the ErbB receptor network
Christoph A Ritter, Marianela Perez-Torres, Cammie Rinehart, et al.
Cancer Research
|
April 20, 2013
Cytotoxic activity of tivantinib (ARQ 197) is not due solely to c-MET inhibition
Ryohei Katayama, Aki Aoyama, Takao Yamori, et al.
FEBS Letters
|
September 17, 1998
Mutational analysis of caveolin-induced vesicle formation. Expression of caveolin-1 recruits caveolin-2 to caveolae membranes
S Li, F Galbiati, D Volonte, et al.
Page
of 24
Search research articles
Search
Showing results (71-80 of 238) with videos related to
Sort By:
Page
of 24
The Journal of Biological Chemistry
|
June 27, 1997
Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth
J A Engelman, C C Wykoff, S Yasuhara, et al.
Science Signaling
|
November 25, 2010
BRAF gene amplification can promote acquired resistance to MEK inhibitors in cancer cells harboring the BRAF V600E mutation
Ryan B Corcoran, Dora Dias-Santagata, Kristin Bergethon, et al.
Oncogene
|
June 29, 2010
H1047R phosphatidylinositol 3-kinase mutant enhances HER2-mediated transformation by heregulin production and activation of HER3
A Chakrabarty, B N Rexer, S E Wang, et al.
The Journal of Biological Chemistry
|
December 10, 1999
Constitutively active mitogen-activated protein kinase kinase 6 (MKK6) or salicylate induces spontaneous 3T3-L1 adipogenesis
J A Engelman, A H Berg, R Y Lewis, et al.
The EMBO Journal
|
November 21, 1998
Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade
F Galbiati, D Volonte, J A Engelman, et al.
Cancer Research
|
May 4, 2012
MEK inhibition leads to PI3K/AKT activation by relieving a negative feedback on ERBB receptors
Alexa B Turke, Youngchul Song, Carlotta Costa, et al.
Cancer Research
|
January 27, 2011
Multiple mutations and bypass mechanisms can contribute to development of acquired resistance to MET inhibitors
Jie Qi, Michele A McTigue, Andrew Rogers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 19, 2007
Human breast cancer cells selected for resistance to trastuzumab in vivo overexpress epidermal growth factor receptor and ErbB ligands and remain dependent on the ErbB receptor network
Christoph A Ritter, Marianela Perez-Torres, Cammie Rinehart, et al.
Cancer Research
|
April 20, 2013
Cytotoxic activity of tivantinib (ARQ 197) is not due solely to c-MET inhibition
Ryohei Katayama, Aki Aoyama, Takao Yamori, et al.
FEBS Letters
|
September 17, 1998
Mutational analysis of caveolin-induced vesicle formation. Expression of caveolin-1 recruits caveolin-2 to caveolae membranes
S Li, F Galbiati, D Volonte, et al.
Page
of 24